Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- GL9.IR
- Price
- 15.90
- Stock movement up
- +0.23 (1.47%)
- Company name
- Glanbia PLC
- Exchange
- (IR ,
- Currency
- EUR )
- Sector
- Consumer Defensive >Packaged Foods
- Market cap
- 3.85B
- Ent value
- 5.43B
- Price/Sales
- 4.55
- Price/Book
- 1.88
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 103.83%
- Trailing P/E
- 57.64
- Forward P/E
- 12.93
- PEG
- -
- EPS growth
- 1.05%
- 1 year return (CAGR)
- 12.53%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
DIVIDENDS
GL9.IR does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 57.64 |
| Price to OCF | 94.72 |
| Price to FCF | 143.89 |
| Price to EBITDA | 31.57 |
| EV to EBITDA | 44.45 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.55 |
| Price to Book | 1.88 |
| EV to Sales | 6.40 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 242.45M |
| EPS (TTM) | 0.26 |
| FCF per share (TTM) | 0.11 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 847.43M |
| Gross profit (TTM) | 282.20M |
| Operating income (TTM) | 82.33M |
| Net income (TTM) | 66.89M |
| EPS (TTM) | 0.26 |
| EPS (1y forward) | 1.23 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 33.30% |
| Operating margin (TTM) | 9.72% |
| Profit margin (TTM) | 7.89% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 275.60M |
| Net receivables | 488.30M |
| Total current assets | 1.50B |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 612.60M |
| Total assets | 3.90B |
| Accounts payable | 595.80M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 897.80M |
| Total liabilities | 1.85B |
| Shareholder's equity | 2.05B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 40.70M |
| Capital expenditures (TTM) | 13.91M |
| Free cash flow (TTM) | 26.79M |
| Dividends paid (TTM) | 27.82M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 3.26% |
| Return on Assets | 1.72% |
| Return on Invested Capital | 2.39% |
| Cash Return on Invested Capital | 0.96% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 15.52 |
| Daily high | 16.06 |
| Daily low | 15.52 |
| Daily Volume | 528K |
| All-time high | 19.55 |
| 1y analyst estimate | 17.91 |
| Beta | 0.44 |
| EPS (TTM) | 0.26 |
| Dividend per share | 0.00 |
| Ex-div date | 23 Mar 2023 |
| Next earnings date | 25 Feb 2026 |
Downside potential
Loading...
Downside potential data
| GL9.IR | S&P500 | |
| Current price drop from All-time high | -18.67% | -0.89% |
| Highest price drop | -52.40% | -19.00% |
| Date of highest drop | 9 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -30.79% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
COMPANY DETAILS
Marketcap
3.85B
Marketcap category
Mid-cap
Description
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; and provision of business services and management solutions, weight management, flavor solutions, and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Employees
5791
Website
Investor relations
-
SEC filings
CEO
Country
Ireland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The small move in Glanbia’s modelled fair value, from €17.71 to €17.74, reflects how recent research is gently recalibrating expectations rather than rewriting the story. With the discount rate held a...
February 5, 2026
What Glanbia’s recent share move tells you Glanbia (ISE:GL9) has recently caught investor attention, with the share price at €16.75 after a 2.1% move in the latest session, prompting a closer look at ...
February 5, 2026
Key market opportunities in the whey protein sector include increasing demand for health and wellness products, growth in sports nutrition, and rising interest in clean-label, high-protein items. Tech...
February 4, 2026
The global cheese market is projected to grow from $208.06 billion in 2025 to $317.61 billion by 2033, driven by a 5.43% CAGR. This growth is fueled by rising demand for protein-rich foods, urbanizati...
January 28, 2026
Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Herbal Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offeri...
December 5, 2025
The global chia seed market is projected to reach USD 7.38 billion by 2033, growing from USD 1.39 billion in 2024, at a CAGR of 20.38% (2025-2033). The rising demand for nutritional supplements and na...
November 26, 2025
Glanbia (ISE:GL9) shares have moved only slightly in recent days. However, the company’s performance over the past month paints a more dynamic picture. Investors may be eyeing the steady upward trend ...
November 13, 2025
The United States Dietary Supplements Market, projected to grow from US$ 54.24 billion in 2024 to US$ 103.56 billion by 2033, is driven by rising health awareness and demand for preventive healthcare,...
November 12, 2025
There's a shift towards plant-based sources like pea, soy, and quinoa, appealing to clean-label and allergen-free seekers. Innovations such as ready-to-drink beverages and gummies are expanding market...
October 22, 2025
The UK and European SlimFast assets have been acquired from Glanbia, which sold the North America portion in September.
October 20, 2025
Next page